4 Of Our 20 Portfolios Dropped More Than 20% In November - Here's Why

Image Source: Pexels

Introduction

Of the 20 stock categories that I follow (see articles here), 4 declined in excess of 20% in November, another 3 by at least 10%, and 8 by lesser amounts, leaving only 5 categories that actually increased. This article highlights the performances of the 4 categories that declined in November, in descending order, and their constituents, and the reasons behind the category declines. 

The 4 Categories That Declined More Than 20%

1. Pure-play Quantum Computing Stocks Portfolio:  DOWN 31.9% in November; UP 33.3% YTD
   • Constituent Returns: RGTI (-42,2%); QBTS (-38.8%); QUBT (-30.0%); IONQ (-21.1%) 
   • Reason(s) for Decline: Because investors:
     • reassessed their lofty valuations,
     • worried about dilution from repeated capital raises, 
     • reacted to skepticism about commercialization timelines, and
     • were concerned about the sector’s
       • speculative nature,
       • high R&D costs, and
       • comparisons to the much larger AI market which amplified the pullback.
   • Article of Interest:
     • What Is Quantum Computing?
2. Pure-play Plant-based Food Stocks Portfolio: DOWN 26.8% in November; DOWN 23.5% YTD
   • Constituent Returns: GUROF (-19.9%); OTLY (-21.8%); BYND (-41.0); LSF (-44.6%)
   • Reason(s) for Decline:
     • Because of shrinking sales, cash burn, and consumer fatigue
3. AI-focused Pure-play Drug Discovery Stocks Portfolio: DOWN 24.9% in November; DOWN 6.3% YTD
   • Constituent Returns: RXRX (-16.1%); ABSI (-25.9%); ABCL (-32.8%)
   • Reason(s) for Decline:
     • Because of valuation fears across the AI sector, uncertain commercialization timelines for AI‑driven drug pipelines, and heavy cash burn with dilution risk. The sell‑off was part of a broader AI correction, but drug discovery names were hit harder due to their speculative nature and lack of near‑term revenue visibility
   • Article of Interest:
     • Using AI In Drug Discovery Transforming The Pharmaceutical Industry - Here's How
4. Cannabis MSO Stocks Portfolio: DOWN 23.7% in November; DOWN 4.6% YTD
   • Constituent Returns: GTBIF (-15.9%); CURLF (-19.1%); TCNNF (-25.7%); VRNO (-33.1%); CRLBF (-37.2%)
   • Reason(s) for Decline: 
     • Because of regulatory setbacks in Washington, continued sector‑wide financial struggles, and investor fatigue after years of losses.

The 3 Categories That Declined By At Least 10% in November

1. Pure-play Cloud Computing Stocks Portfolio: DOWN 12.1%
   • ​​​​​​​Constituents: TEAM; CRM; NOW; HUBS; WDAY; DDOG; SNOW; ZM
   • Article of Interest:
     • What Is Cloud Computing? What Is SaaS?
2. Pure-play CyberSecurity Stocks Portfolio: DOWN 13.9%​​​​​​​
   • ​​​​​​​​​​​Constituents: PANW; CRWD; NET; ZS; CYBR
   • Article of Interest:
     • Cyber Security Companies Now Using AI-Driven Attack Detection
3. Pure-play Cryptocurrency ETFs Portfolio: DOWN 19.3%​​​​​​​
   • ​​​​​​​​​​​​​​Constituents: BTC; ETH
   • Articles of Interest:
     • Bitcoin And Ethereum: How Do They Differ?
     • Here’s How To Differentiate Between Bitcoin, Altcoin, Stablecoin, Meme Coin And Shitcoin Cryptocurrencies
     • What Are "Shitcoins"?

The 8 Categories That Declined Less Than 10% in November

1. Mega-cap Stocks Portfolio: DOWN 0.3%
   • ​​​​​​​​​​​​​​Constituents: NVDA; MSFT; AAPL; GOOGL; AMZN; META;TSLA; AVGO
2. Pure-play AI Semiconductor Equipment/Material Stocks Portfolio: DOWN 0.6%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: ASML; LRCX; AMAT; KLAC
   • Article of Interest:
     • These 5 Barriers May Impede Advancements In Semiconductor Production
3. Pure-play AI Fabless Semiconductor Stocks Portfolio: DOWN 5.9%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: NVDA; QCOM; AMD; AVGO; MRVL; MPWR
4. Pure-play Custom Design Semiconductor Stocks Portfolio: DOWN 7.9% 
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: SNPS; CDNS
5. Pure-play Critical Mineral Stocks Portfolio: DOWN 8.1%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: CCJ; UEC; LAC; SLI; SGML; NMG; PLLTL; TLGRF; AMLIF
   • Article of Interest:
     • Here's How Rare Earth Metals & Critical Mineral Stocks Differ From Each Other
6. Cannabis LP Stocks Portfolio: DOWN 8.3%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: CGC; CRON; ACB; OGI; TLRY
7. Pure-play Psychedelic Compound-based Stocks Portfolio: DOWN 8.4%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: ATAI; GHRS; CMPS; MNMD
8. Pure-play Rare Earth Metal Stocks Portfolio: DOWN 9.6%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: MP; USAR; LYSCF; NB; UURAF; ILKAF; ARAAF; MKNGF; ARAAF; VTMXF; NOURF
   • Article of Interest:
     • What You Need To Know About Rare Earth Metals Production, Reserves And Stocks

The 5 Categories That INCREASED In November

1. Gold/Silver ETFs Portfolio: UP 16.1%
   • ​​​​​​​​​​​​​​​​​​​​​​​​​​​​Constituents: GDX; GDXJ; SGDJ; SIL; GOAU
   • Articles of Interest:
     • Gold & Silver Equities Are Up Dramatically YTD And Greater Returns Are Expected Going Forward! 
     • Frenzied Stampede Into Gold Stocks Coming Soon! Here's Why
     • Find The Best Gold Stocks By Analyzing Their "5 Ms" - Here's How
2. Pure-play Semiconductor Assembly, Test & Packaging Stocks Portfolio: UP 6.3%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: ASX; AMKR
3. Pure-play Semiconductor Foundry Stocks Portfolio: UP 3.3%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: TSM; TSEM; GFS; UMC
4. Integrated Device Manufacturer (IDM) Stocks Portfolio: UP 3.2%
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: MU; MCHP; ADI; IFNNY; TXN; NXPI; INTC; STM
5. Luxury Goods Stocks Portfolio: UP 3.0%​​​​​​​
   • ​​​​​​​​​​​​​​​​​​​​​Constituents: TPR; SIG; CPRI; LVMUY; CFRUY; PPRUY

Summary

On average, the above 20 portfolios were DOWN 4.9% in November.

---

More By This Author:

All 6 AI Semiconductor Stock Categories Fell Last Week - Here's Why
Pure-Play Quantum Computing Stocks Down 21% Last Week - Here's Why
Worst Day Ever For MSO Cannabis Stocks - Here's Why